ASC4START: A Phase IIIb, Open-Label, Randomized Study of Tolerability and Efficacy of Asciminib Versus Nilotinib in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia in Chronic Phase
| Autor: | Hochhaus, Andreas, Saussele, Susanne, Mahon, Francois-Xavier, Pilipovic, Virginia *, Zhang, Yifan *, Schuld, Peter *, Brümmendorf, Tim H. |
|---|---|
| Zdroj: | In Blood 15 November 2022 140 Supplement 1:6787-6788 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|